Stock Events

Stock Events

UroGen Pharma (URGN) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.05

-0.88

-0.72

-0.55

Details

Expected EPS

-0.864712

Actual EPS

-1.05

Surprise EPS

-0.19

Surprise Percent

+21.43%

Description

UroGen Pharma (URGN) has reported earnings of -1.05 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.